168 related articles for article (PubMed ID: 35308885)
1. Efficacy and Safety of Q10 Ubiquinol With Vitamins B and E in Neurodevelopmental Disorders: A Retrospective Chart Review.
Cucinotta F; Ricciardello A; Turriziani L; Mancini A; Keller R; Sacco R; Persico AM
Front Psychiatry; 2022; 13():829516. PubMed ID: 35308885
[TBL] [Abstract][Full Text] [Related]
2. Phelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment.
Harony-Nicolas H; De Rubeis S; Kolevzon A; Buxbaum JD
J Child Neurol; 2015 Dec; 30(14):1861-70. PubMed ID: 26350728
[TBL] [Abstract][Full Text] [Related]
3. Inattention and hyperactivity/impulsivity among children with attention-deficit/hyperactivity-disorder, autism spectrum disorder, and intellectual disability.
McClain MB; Hasty Mills AM; Murphy LE
Res Dev Disabil; 2017 Nov; 70():175-184. PubMed ID: 28957735
[TBL] [Abstract][Full Text] [Related]
4. Case study: organizing outpatient pharmacological treatment of bipolar disorder in autism, intellectual disability and Phelan-McDermid syndrome (22q13.3 deletion syndrome).
Rysstad AL; Kildahl AN; Skavhaug JO; Dønnum MS; Helverschou SB
Int J Dev Disabil; 2022; 68(3):378-387. PubMed ID: 35603006
[TBL] [Abstract][Full Text] [Related]
5. 22q13 deletion syndrome: communication disorder or autism? Evidence from a specific clinical and neurophysiological phenotype.
Ponson L; Gomot M; Blanc R; Barthelemy C; Roux S; Munnich A; Romana S; Aguillon-Hernandez N; Malan V; Bonnet-Brilhault F
Transl Psychiatry; 2018 Aug; 8(1):146. PubMed ID: 30089781
[TBL] [Abstract][Full Text] [Related]
6. Effects of Atomoxetine in Individuals with Attention-Deficit/Hyperactivity Disorder and Low-Functioning Autism Spectrum Disorder.
Kilincaslan A; Mutluer TD; Pasabeyoglu B; Tutkunkardas MD; Mukaddes NM
J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):798-806. PubMed ID: 27228116
[TBL] [Abstract][Full Text] [Related]
7. Association of maternal diabetes with neurodevelopmental disorders: autism spectrum disorders, attention-deficit/hyperactivity disorder and intellectual disability.
Chen S; Zhao S; Dalman C; Karlsson H; Gardner R
Int J Epidemiol; 2021 May; 50(2):459-474. PubMed ID: 33221916
[TBL] [Abstract][Full Text] [Related]
8. [Intellectual developmental disability overlapping with autism spectrum disorder and attention deficit-hyperactivity disorder].
Mulas F; Rojas M
Medicina (B Aires); 2018; 78 Suppl 2():63-68. PubMed ID: 30199368
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of the clinical phenotype in Phelan-McDermid syndrome.
Burdeus-Olavarrieta M; San José-Cáceres A; García-Alcón A; González-Peñas J; Hernández-Jusdado P; Parellada-Redondo M
J Neurodev Disord; 2021 Jul; 13(1):26. PubMed ID: 34246244
[TBL] [Abstract][Full Text] [Related]
10. Sensory Processing Phenotypes in Phelan-McDermid Syndrome and
Lyons-Warren AM; McCormack MC; Holder JL
Brain Sci; 2022 Jan; 12(2):. PubMed ID: 35203901
[TBL] [Abstract][Full Text] [Related]
11. Co-occurrence of Metachromatic Leukodystrophy in Phelan-McDermid Syndrome.
Mingbunjerdsuk D; Wong M; Bozarth X; Sun A
J Child Neurol; 2021 Feb; 36(2):148-151. PubMed ID: 32991243
[TBL] [Abstract][Full Text] [Related]
12. School dysfunction in youth with autistic spectrum disorder in Taiwan: The effect of subtype and ADHD.
Chiang HL; Kao WC; Chou MC; Chou WJ; Chiu YN; Wu YY; Gau SS
Autism Res; 2018 Jun; 11(6):857-869. PubMed ID: 29427542
[TBL] [Abstract][Full Text] [Related]
13. Autism spectrum disorder in Phelan-McDermid syndrome: initial characterization and genotype-phenotype correlations.
Oberman LM; Boccuto L; Cascio L; Sarasua S; Kaufmann WE
Orphanet J Rare Dis; 2015 Aug; 10():105. PubMed ID: 26306707
[TBL] [Abstract][Full Text] [Related]
14. A Brazilian cohort of individuals with Phelan-McDermid syndrome: genotype-phenotype correlation and identification of an atypical case.
Samogy-Costa CI; Varella-Branco E; Monfardini F; Ferraz H; Fock RA; Barbosa RHA; Pessoa ALS; Perez ABA; Lourenço N; Vibranovski M; Krepischi A; Rosenberg C; Passos-Bueno MR
J Neurodev Disord; 2019 Jul; 11(1):13. PubMed ID: 31319798
[TBL] [Abstract][Full Text] [Related]
15. Phelan-McDermid syndrome: a review of the literature and practice parameters for medical assessment and monitoring.
Kolevzon A; Angarita B; Bush L; Wang AT; Frank Y; Yang A; Rapaport R; Saland J; Srivastava S; Farrell C; Edelmann LJ; Buxbaum JD
J Neurodev Disord; 2014; 6(1):39. PubMed ID: 25784960
[TBL] [Abstract][Full Text] [Related]
16. Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency.
Soorya L; Kolevzon A; Zweifach J; Lim T; Dobry Y; Schwartz L; Frank Y; Wang AT; Cai G; Parkhomenko E; Halpern D; Grodberg D; Angarita B; Willner JP; Yang A; Canitano R; Chaplin W; Betancur C; Buxbaum JD
Mol Autism; 2013 Jun; 4(1):18. PubMed ID: 23758760
[TBL] [Abstract][Full Text] [Related]
17. Understanding Behavior in Phelan-McDermid Syndrome.
Landlust AM; Visser L; Flapper BCT; Ruiter SAJ; Zwanenburg RJ; van Ravenswaaij-Arts CMA; van Balkom IDC
Front Psychiatry; 2022; 13():836807. PubMed ID: 35693963
[TBL] [Abstract][Full Text] [Related]
18. A 9-year-old-girl with Phelan McDermid Syndrome, who had been diagnosed with an autism spectrum disorder.
Görker I; Gürkan H; Demir Ulusal S; Atlı E; Ikbal Atlı E
Balkan J Med Genet; 2016 Dec; 19(2):85-90. PubMed ID: 28289594
[TBL] [Abstract][Full Text] [Related]
19. Increased rates of cerebral protein synthesis in Shank3 knockout mice: Implications for a link between synaptic protein deficit and dysregulated protein synthesis in autism spectrum disorder/intellectual disability.
Torossian A; Saré RM; Loutaev I; Smith CB
Neurobiol Dis; 2021 Jan; 148():105213. PubMed ID: 33276083
[TBL] [Abstract][Full Text] [Related]
20. Phelan-McDermid syndrome: clinical report of a 70-year-old woman.
Verhoeven WM; Egger JI; Cohen-Snuijf R; Kant SG; de Leeuw N
Am J Med Genet A; 2013 Jan; 161A(1):158-61. PubMed ID: 23166010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
